Consistent with the experimental data in vitro and in vivo, higher expression of NHE9 was correlated with a poor CRT response and less decrease in T and N stage in ESCC patients, which further confirmed that NHE9 is a predictor of CRT resistance and ultimately poor survival. Here, SLC9A9 is linked to esophageal squamous cell carcinoma.